The Digital Pills Market To Grow With Techno-Savvy Inputs
Persistence Market Research has come up with its latest finding in the form of “The Digital Pills Market” report, wherein [...]
Transforming the National Medicines Policy with a vision for the future
Australia’s National Medicines Policy (NMP) was launched 22 years ago. Since the NMP was first launched, Australia has seen significant [...]
Digital Health Tools Are Finding Business Models – IQVIA’s 2021 Read on the Health of Digital Health
In the Age of COVID, over 90,000 new health apps were released, as the supply of digital therapeutics and wearables [...]
Health Economics & Outcomes Research (HEOR) Services Market: Global Opportunity Analysis and Industry Forecast, 2020-2027
Health Economics & Outcomes Research (HEOR) Services Market: Global Opportunity Analysis and Industry Forecast, 2020-2027 Health Economics & Outcomes Research [...]
Pharma Rewards Democrat in Cash Following His Opposition of Pelosi’s Drug Pricing Bill
Representative Scott Peters was rewarded with large sums of cash donations to his campaign by pharma and lobbyists the day [...]
Social prescribing in community pharmacy: a systematic review and thematic synthesis
Abstract Background: Social prescribing is a tool for healthcare professionals to help connect people in their communities to local, non-clinical [...]
Democrats and Republicans Unite in Pushing for Medicare Negotiation Legislation, Could Save $500 Billion
Bipartisan support is building for legislative mechanisms that would lead to reduced healthcare costs in the United States. One key [...]
Negotiating the changing NHS landscape: five critical shifts the pharma industry must embrace
As the long-awaited Health and Care Bill begins its passage through parliament, Oli Hudson looks at five critical changes resulting [...]
Payers Must Cover HIV Prevention Drugs Without Cost-Sharing in Two Months
Federal regulations will require payers to cover HIV prevention drugs and care. Gilead’s HIV drug Truvada has faced criticism due [...]
Injecting Price Competition into Medicare Part B Drugs
Medicare Part B, which covers outpatient physician services, pays for physician-administered drugs by reimbursing physicians the average cost for each [...]
NHS shares English hospital data with dozens of companies
According to an analysis by the Financial Times, more than 40 companies, from the world’s largest management consultancy and pharmaceutical [...]
Why Are Drug Manufacturers Disregarding Clinical Trial Transparency Regulations?
A recent study found that most pharmaceutical companies do not meet rules demanding transparency in clinical trials. This lack of [...]
Big Data in the Healthcare & Pharmaceutical Industry: 2018 – 2030 – Opportunities, Challenges, Strategies & Forecasts
The report provides answers to the following key questions: – How big is the Big Data opportunity in the healthcare [...]
OKRA.ai collaborates with AWS for Health initiative from Amazon Web Services
OKRA.ai has announced a collaboration with the AWS for Health initiative from Amazon Web Services (AWS) to help upskill pharmaceutical [...]
IQVIA Publishes Report on 2021 Digital Health Trends
The IQVIA Institute has published a report detailing digital trends for 2021. The report highlights the use of wearables and [...]
Sanitized Propaganda: The Fortress of Lies to Censor Truths about Covid-19
By Dr. Gary Null and Richard Gale Global Research, July 22, 2021 We continue to make efforts to remind people [...]
Reduced Medical Spending Associated With Integrated Pharmacy Benefits
Members covered by an integrated pharmacy benefit (as opposed to a pharmacy carve-out) experienced slower growth in medical spending. ABSTRACT [...]
Consumer Health Apps and Digital Health Tools Proliferate, Improving Quality and Health Outcomes for Patients, Says New Report from IQVIA Institute
Consumer health apps are the most widely available and used digital tools. More than 90,000 new apps were released in [...]
All About the Value, Evidence and Access Marketplace: Interview with Scientist.com Category Experts
Scientist.com, the parent company of HealthEconomics.Com, recently announced the newly rebranded Value, Evidence and Access Marketplace – an online solution [...]
AstraZeneca’s newly acquired Soliris is overpriced in myasthenia gravis, cost watchdog says
AstraZeneca's newly acquired Soliris is overpriced in myasthenia gravis, cost watchdog says nhigginsdunn Fri, 07/23/2021 - 14:46 Read the source [...]
Drug Discovery Informatics Market Size Is Projected to Reach $5.62 Billion By 2028 | Cagr: 11.4%: Polaris Market Research
NEW YORK The global drug discovery informatics market size is expected to reach USD 5.62 billion by 2028 . A [...]
US Pharmaceutical and Healthcare Industry Report 2021: Prescription Drugs, Generic Drugs, Otc …
Tweet Dublin, Dublin, The "Pharmaceutical and Healthcare Industry in the US - Forecast and Analysis 2021" report has been added [...]
New Zealand drug agency provides model to help insulate NICE from impacts of post-Brexit trade deals | myScience / news / wire
An investigation by CASP researchers suggests safeguards put in place in New Zealand to protect drug policy offer important lessons [...]
Biogen execs blame critics, the media for spurring ‘misinformation’ as Aduhelm launch lags expectations
Biogen execs blame critics, the media for spurring 'misinformation' as Aduhelm launch lags expectations nhigginsdunn Thu, 07/22/2021 - 11:25 Read [...]
MIT’s Sloan School and Computer Science and Artificial Intelligence Lab researchers together with leading pharma data scientists use crowdsourcing to better forecast drug approvals
CAMBRIDGE, Mass. , July 20, In late 2019, researchers at the MIT Laboratory for Financial Engineering (LFE) and the MIT [...]